AZIO AI HOLDINGS, INC. Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $9.2M+392.7% YoYTTM through 30 Jun 2026
Net Income $5.2MTTM through 30 Jun 2026
Free Cash Flow -$124.6MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| EBITDA Margin | -315.6% |
| Operating Margin | -651.2% |
| Net Margin | 56.6% |
Returns
N/A (negative equity)ROE
33.5%ROA
Balance Sheet Health
Debt / EquityN/A (negative equity)
Current Ratio0.26x
Net Debt$461K
Cash & Equivalents$142K
Quality Metrics
Altman Z-Score-17.90
Piotroski F-Score3 / 9
FCF Margin-1,352.8%
Earnings-Beat Rate50.0%
Multi-Year Trend
RevenueFY2025: $5.9M
Diluted EPSFY2025: $-11.54
Dividend
No dividend
Capital Allocation
R&D Spend$65.3K
Capex Intensity51.2%
Segment Performance
Figures as of 31 Dec 2025
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Medical Supplies | $5.6M | View detailsThe company is pivoting operational focus toward medical supplies distribution following the late 2024 acquisition of Maddox Industries. | |
| Electric Vehicles | $356.4K | -82.2% | View detailsModerating the pace of expansion within this segment due to reduced federal and state incentives, cost pressures, and tariff increases. |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.